Breakdown of ethylene glycol dinitrate (EGDN) in blood in vitro results in the liberation of inorganic nitrite and ethylene glycol mononitrate (EGMN). The nitrite is oxidized to inorganic nitrate but the EGMN is more resistant to further degradation.
Ethylene glycol dinitrate (EGDN) is used in the explosives industry as one of the components of anti-freeze dynamite. It is volatile and is readily absorbed via the lungs and skin (Gross, Bock, and Hellrung, I942). Consequently, some of the workers engaged in the manufacture of dynamite may absorb EGDN throughout their working day. In common with other organic nitrates, such as nitroglycerine, EGDN lowers the blood pressure and often causes headaches in the workers (Carmichael and Lieben, i963) . Whereas the metabolism of nitroglycerine and certain other organic nitrates and their effects have been well documented, there is a lack of information on the behaviour of EGDN in the body. This paper, therefore, is concerned with the metabolism of EGDN and some of the pharmacological properties of EGDN and its metabolites in the rat.
Methods
The animals used were specific pathogen-free female rats of the Alderley Park (albino) strain, with body weights in the range 200 to 250 g. EGDN (supplied by I.C.I. Nobel Division as a 99.i% pure material) was used as a io% solution in corn oil for the in vivo studies and as a I % solution in ethanol for in vitro work. Ethylene glycol mononitrate (EGMN) was synthesized by the method of Ferris, McLean, Marks, and Emmons (1953) and was used either as a 2% corn oil solution or as a o-I% aqueous solution.
Rats were anaesthetized by an intraperitoneal injection of 60 mg./kg. sodium pentobarbitone (Nembutal). The blood pressures of anaesthetized rats were recorded from a cannulated carotid artery by means of a Devices pressure transducer; mean blood pressures were obtained by electronic damping of the transducer output. Display was by a Devices M4 high-speed pen-recorder. The blood pressure readings were noted I8 minutes after the injection of the anaesthetic when it was known that the cardiovascular system had stabilized.
Blood samples were taken from the carotid artery into tubes containing i mg. sodium fluoride and 2 mg. potassium oxalate per ml. of blood to prevent clotting and to inhibit the breakdown of inorganic nitrite and EGDN in the sample. Since complete inhibition of breakdown was not possible, the blood was analysed immediately after collection.
For the in vitro studies, blood was taken from a Metabolism of Ethylene Glycol Dinitrate and its Influence on the Blood Pressure of the Rat 32I carotid artery into heparinized tubes. Plasma and erythrocytes were separated by centrifugation. Plasma was used undiluted; erythrocytes were washed and centrifuged three times with o02 N phosphate buffer at pH 7-4 and made up to the original blood volume with the phosphate buffer for use in the experiments. Immediately after removal from an animal, or at the end of an in vitro experiment, I ml. of blood was diluted with I ml. of water and shaken with IO ml. of ether for I minute. Free EGDN present in the blood was transferred completely into the ether layer, whereas the inorganic nitrate and nitrite remained in the aqueous layer.
EGDN was determined in 5 ml. of the ether extract by a modification of the method of Hasegawa, Sato, Yoshikawa, Sakabe, Yamaguchi, and Hotta (I962). Absorbence was measured on a Unicam SP6oo spectrophotometer at 540 mt and the EGDN present in i ml.
of whole blood was calculated from calibration curves. Any EGMN present in the ether extract was not converted to nitrite under these conditions and consequently did not intefere with the estimation.
The aqueous layer remaining after the original ether extraction of the blood was extracted again with IO ml. ether to remove any EGMN remaining. After separation, the blood was analysed for inorganic nitrate and inorganic nitrite on the Technicon AutoAnalyser as previously described (Litchfield, I967).
Blood was analysed for EGMN by a modification of a gas chromatographic method developed for the estimation of EGDN (Williams, Murray, and Gibb, I966) . Two millilitres of blood were shaken with IO ml. of ether for i minute, and the ether layer was removed, made to volume (5 tO 50 ml.) and dried with anhydrous sodium sulphate. Two-microlitre portions of this ether extract were injected into a Wilkins I522 gas chromatograph with an electron capture detector, interspaced with standard samples containing known quantities of EGMN. The column was a 30% E30I silicone gum phase on acid-washed BDH celite 8o to i2o mesh in a 5 ft. x t in. stainless steel tube. Column, injector, and detector temperatures were 1300C., i65°C., and i65°C. respectively; nitrogen gas flow was 6o ml./min. Every four hours the system was conditioned with 5-!tl. samples of an ethyl alcohol solution of nitroglycerine (i pg./ml.). Under these conditions the retention times for EGMN and EGDN were I-3 minutes and I-9 minutes respectively, giving adequate separation for the estimation. As the recovery of added EGMN from blood was 80% (+ 2%), a correction was applied to all samples.
Organic nitrite in the blood was estimated by extracting 2 ml. of blood with io ml. of ether. Five millilitres of ether extract were then mixed with 7 ml. ethyl alcohol and i ml. water and the nitrite was analysed by the colorimetric procedure of Shinn (I94I).
Groups of rats were placed in metabolism cages and the urine, separated from the faeces (Gage, I96I) 
Results
Blood was taken from human subjects, rabbits, and rats that had never been exposed to organic nitrates and was analysed for inorganic nitrate and inorganic nitrite. In all cases nitrite was found to be below the level of sensitivity of the method of estimation (<oIi ug./ml.) and the nitrate concentrations were approximately i-o ug. /ml.
Metabolism in vitro Rat blood was incubated at 370C. with 50 ,tg./ml. EGDN and samples were withdrawn at intervals for estimation of EGDN breakdown and the production of inorganic nitrate and nitrite. The results summarized in Table I show that breakdown was substantially complete within two hours. Inorganic nitrite was mostly (Heppel and Porterfield, 1949; Litchfield, I967) . Consequently it does not appear as a final metabolite in vitro nor is it excreted in vivo.
The liberation of inorganic nitrite during the metabolism of EGDN is consistent with work on other organic nitrates such as erythritol tetranitrate and pentaerythritol tetranitrate (Yagoda and von Oettingen, I944) and nitroglycerine (Needleman and Hunter, I965), when inorganic nitrite was found both in vitro and in vivo. However, our results differ from the findings of Hasegawa and Sato (I963a, b), who found that inorganic nitrite was not liberated after an injection of EGDN in the rabbit. This disagreement cannot be due to a species difference, because when we repeated our experiments with the rabbit, large amounts of inorganic nitrite were detected in the blood. The disagreement may be due to the methods of analysis used, but since Hasegawa and Sato have not published their nitrite method in detail, it is not possible to clarify this point.
The results we obtained for normal blood nitrate levels also disagree with those published by the Japanese workers (Hasegawa et al., I962; Hasegawa and Sato, I963a) . Their nitrate values are 20 times greater than the values we found for rat, rabbit, and man, and much greater than values previously reported for man, which have ranged from I fig./ml. (Carr, I958) to 3-2 to 6-2 p,g./ml. (Cass and Cohen, I96I) .
Most of the inorganic nitrate resulting from the metabolism of EGDN must derive from the oxidation of inorganic nitrite. It is possible that some might be formed by a direct hydrolysis of the EGDN molecule, but there is no evidence to support this from the present study or from the literature. Inorganic nitrate is relatively resistant to further metabolism (Greene and Hiatt, 1954) 
